Key points are not available for this paper at this time.
Background: Due to the rapid advancement of technology, artificial intelligence (AI) has become extensively used for the diagnosis and prognosis of various diseases, such as lung cancer. Research in the field of literature has demonstrated that artificial intelligence (AI) can be valuable in the timely detection of lung cancer and the formulation of an effective treatment plan. This study aims to conduct a bibliometric analysis to examine and illustrate the specific areas of focus, research frontiers, evolutionary processes, and trends in existing research on artificial intelligence in the context of lung cancer. Methods: Publications on AI in lung cancer were selected from the SCIE and ESCI indexes on September 19, 2023. The examination of nations, academic publications, organizations, writers, citations, and terms in this domain was visually analyzed with InCites and VOSviewer. Results: In this study, a total of 4275 publications were selected and analyzed. Artificial intelligence-related lung cancer publications have increased significantly in the last 5 years. China and the USA have contributed the most to the literature in this field (1418 publications with 13.92 citation impacts and 1117 publications with 37.34 citation impacts, respectively). The institution with the highest contribution was "Chinese Academy of Sciences," with 118 publications and 29.09 citation impacts. Among the research categories, "Radiology, Nuclear Medicine & Imaging", "Oncology", and "Engineering, Biomedical" were in first place. Conclusion: The USA and China have always been leaders in this field and will continue to be for some time. Research in countries such as the Netherlands is increasing. However, research collaboration has to be strengthened in developing countries.
Adem Gencer (Mon,) studied this question.